| Log in

Biocon subsidiary Syngene International looking to raise over $50M

19 August, 2014

Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country’s largest drug research and development services unit, is looking to raise over ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Biocon plans IPO for IVFA-backed drug discovery services arm Syngene

Biocon plans IPO for IVFA-backed drug discovery services arm Syngene

Jasleen Kaur Batra 3 years ago
Biocon Ltd is looking to offload up to 15 per cent in its research arm Syngene...
India Value Fund buying 10% in Biocon's research arm Syngene for $62M

India Value Fund buying 10% in Biocon’s research arm Syngene for $62M

Shruti Ambavat 3 years ago
Mid-market buyout specialist private equity firm India Value Fund Advisors ) ...
Biocon’s arm Syngene appoints Peter Bains as CEO

Biocon’s arm Syngene appoints Peter Bains as CEO

Jasleen Kaur Batra 3 years ago
Syngene International, a subsidiary of biopharmaceutical major Biocon Ltd, has...
No Comments

Biocon subsidiary Syngene International looking to raise over $50M

Powered by WordPress.com VIP